Emcure, Biological E License Three ICMR Biomedical Technologies For Commercial Use - Sahi

1. Emcure, Biological E License Three ICMR Biomedical Technologies For Commercial Use  Sahi
2. ICMR transfers indigenous cervical cancer drug and vaccine technologies to Emcure and Biological E  BusinessLine
3. ICMR’s PatentMitra Initiative Marks Major Milestone with Transfer of Three Key Biomedical Innovations to Industry Partners  drugscontrol.org
4. ICMR facilitates licensing of 3 Indigenous Biomedical Technologies to Indian pharmaceutical & vaccine manufacturers  News On AIR
5. SHetA2: India's Indigenous Drug Candidate For Cervical Cancer  Health and Me

source https://news.google.com/rss/articles/CBMivAFBVV95cUxQX1A1STA1QXN4RGp6OG1oWWhfWEIzYnl1SG91MXBHMlE2c3ZCTkJ1RW9Td1dhUVNLRXB4bDJ2ODZmUlloMVI1dUtocTFndDNoTW5iZ3d1TFNBbzhLZnFWNDVJSFA1MC1UQjZGLTlxS0oxM0ZmbzNmZVBEb0xPX2ljQWNGRm1GVlRjeHloak9tYWp6Unh2VHJDWG9nRkxJOTNoRm9iX2huM0ZRX1BIUnFmWGRuTlpMY3pPejFBaQ?oc=5